Literature DB >> 10626661

Neurotrophic role of interleukin-6 and soluble interleukin-6 receptors in N1E-115 neuroblastoma cells.

J Knezevic-Cuca1, K B Stansberry, G Johnston, J Zhang, E T Keller, A I Vinik, G L Pittenger.   

Abstract

Interleukin 6 (IL-6) plays a role in physiological and pathophysiological processes in neuronal cells. We studied whether IL-6 plays a role in neuroblastoma cells in culture. These studies demonstrate that N1E-115 cells constitutively express IL-6 but not IL-6R. Exogenous IL-6 stimulated neuronal proliferation in a dose-dependent manner. Under serum-free conditions soluble IL-6 receptors (sIL-6R) alone or in combination with IL-6 exerted significant proliferative effects, while IL-6 alone failed to promote cell proliferation. Neutralizing anti-IL-6 antibody caused a 30-40% reduction in IL-6 mediated proliferation. Our results suggest the importance of IL-6/sIL-6R for proliferation and survival of N1E-115 adrenergic neuroblastoma cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10626661     DOI: 10.1016/s0165-5728(99)00151-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  5 in total

1.  Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease extent and prognosis in neuroblastoma.

Authors:  Rachel A Egler; Susan M Burlingame; Jed G Nuchtern; Heidi V Russell
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

Review 2.  Inflammation, depression and dementia: are they connected?

Authors:  Brian E Leonard
Journal:  Neurochem Res       Date:  2007-08-20       Impact factor: 3.996

3.  Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells.

Authors:  Tasnim Ara; Liping Song; Hiroyuki Shimada; Nino Keshelava; Heidi V Russell; Leonid S Metelitsa; Susan G Groshen; Robert C Seeger; Yves A DeClerck
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

4.  Tumor-derived macrophage migration inhibitory factor (MIF) inhibits T lymphocyte activation.

Authors:  Xiaocai Yan; Rimas J Orentas; Bryon D Johnson
Journal:  Cytokine       Date:  2006-03-07       Impact factor: 3.861

Review 5.  Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy.

Authors:  April Ann Cox; Yves Sagot; Gael Hedou; Christina Grek; Travis Wilkes; Aaron I Vinik; Gautam Ghatnekar
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-02       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.